Becton, Dickinson and Company

Babson Diagnostics, Inc. is a healthcare technology company based in Austin, Texas, focused on revolutionizing blood testing by enabling lab-quality diagnostics in retail settings such as pharmacies and grocery stores. Founded in 2017, the company has developed an innovative device that collects blood samples using only a small volume of capillary blood from the finger, significantly reducing the amount needed compared to traditional venipuncture methods. This approach not only simplifies the blood collection process but also ensures that results are accurate and can be delivered within a short wait time. By analyzing these samples at CLIA-certified clinical laboratories, Babson Diagnostics aims to make diagnostic testing more accessible and convenient for consumers.

Valley Health System is a regional healthcare system that serves residents in northern New Jersey and southern New York. It is comprised of The Valley Hospital, Valley Home Care, and Valley Medical Group. Its services include cardiology, oncology, women’s and children’s services, emergency care, orthopedics, and neurosciences. Through its comprehensive inpatient and outpatient programs, highly skilled home care services, community-based medical practices, and wellness programs, and collaborations with some of the world's leading healthcare organizations, it is dedicated to keeping communities healthy.

Northeast valley health corporation (NEVHC) is one of the nation's community health centers. They are a nonprofit organization, focused on preventing and alleviating health issues. While their patients are united by their experience of medical need, they come from every walk of life and background. The mission of northeast valley health corporation is to provide, safe and comprehensive healthcare to the medically underserved residents of los angeles county, particularly in the san fernando and santa clarita valleys, in a manner that is sensitive to the economic, social, cultural, and linguistic needs of the community.

HealthNet provides high-quality medical, dental, behavioral health care and support services to people of all age, regardless of insurance.

Share Ourselves offers personalized care as a means to deliver quality services, improve population health and stability, and reduce costs. They also provides pediatric care, women's health, behavioral health, clinical pharmaceutical services, food pantry, financial assistance, homeless services, health education, case management, and an OB program.

Wahiawā Health provides access to affordable, quality health care and wellness services to promote a healthy community.

Day Zero Diagnostics Inc. is an infectious disease diagnostics company focused on developing rapid, sequencing-based diagnostics that identify bacterial pathogens and their antibiotic resistance profiles. The company employs advanced technologies such as Blood2Bac, which enhances bacterial DNA recovery from clinical samples, and BacDetect, designed for the swift detection of bacterial DNA. Its Keynome ID algorithm classifies bacterial species, while Keynome g-AST utilizes machine learning for genomic antibiotic susceptibility testing. Additionally, Day Zero maintains MicrohmDB, a comprehensive database that integrates whole genome sequencing data with resistance and susceptibility profiles of clinically relevant pathogens. Founded in 2016 and based in Boston, Massachusetts, Day Zero aims to transform infectious disease diagnostics by providing complete diagnoses—including species identification and antibiotic resistance—within hours, significantly improving treatment outcomes and reducing costs associated with prolonged diagnostic processes.

Cytognos is a privately held company that focuses on providing flow cytometry solutions tailored for blood cancer diagnosis, minimal residual disease (MRD) detection, and immune monitoring research related to blood diseases. The company manufactures a range of products, including reagents, devices, and software designed for use in flow cytometry laboratories. Cytognos aims to enhance the understanding of patient data through its intuitive and powerful solutions, making significant contributions to in vitro diagnostics and life science research.

Scanwell Health, Inc. designs and develops an innovative urine testing kit that provides clinical-grade results through a smartphone application. Founded in 2018 and headquartered in Los Angeles, California, the company offers a urinary tract infection test kit that is FDA-cleared. This product allows users to receive same-day test results and connect with an online doctor’s office for immediate treatment and prescription of antibiotics. By facilitating accessible and affordable healthcare, Scanwell Health aims to empower individuals to take charge of their health proactively.

Tissuemed Ltd. is a medical technology company based in Leeds, United Kingdom, specializing in the development of tissue-based therapeutic devices. Founded in 1985, Tissuemed focuses on creating innovative surgical sealant films designed to effectively seal tissues and prevent leaks of air, blood, and fluids, including cerebrospinal fluid during surgical procedures. The company's flagship product, the TissuePatch™ family, emerged from extensive research and development efforts aimed at addressing leakage complications in surgery. Tissuemed also distributes biological membranes for surgical reconstructions and offers services such as polymer synthesis, formulation of thin films, and chemical testing. Its products are marketed through a network of distributors both in the UK and internationally. The company has established a strong reputation for innovation and scientific expertise in the medical technology field.

Venclose, Inc. is a medical technology company founded in 2014 and based in San Jose, California. The company specializes in developing endovenous radiofrequency ablation therapy systems aimed at treating chronic venous insufficiency. Venclose's solutions focus on improving both physician and patient experiences by offering a minimally invasive method to close damaged veins and restore healthy blood flow. Their technology features enhanced ease of navigation and positioning, provides real-time data during procedures to aid in treatment decisions, and includes a straightforward catheter plug-in, enabling doctors to effectively treat venous reflux.

Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company focuses on developing advanced robotic systems that enhance the efficiency of minimally invasive surgical procedures. Its innovative surgical robot combines virtual reality with human-like robotics, allowing for greater precision and control during complex surgeries. Designed for abdominal access, the Vicarious Surgical Robotic System features 3D visualization and operates through a single port, which minimizes invasiveness and promotes faster patient recovery. This compact and portable system can be easily integrated into existing operating rooms, aiming to improve patient outcomes and reduce healthcare costs.

HealthNet provides high-quality medical, dental, behavioral health care and support services to people of all age, regardless of insurance.

Tepha, Inc. is a medical device company based in Lexington, Massachusetts, specializing in the development and manufacturing of medical device components utilizing proprietary biomaterial technology. Founded in 1998, the company focuses on absorbable biomaterials derived from polyhydroxyalkanoates (PHAs), engineered through recombinant DNA technology. Tepha's product offerings include monofilament sutures for soft tissue approximation, monofilament meshes for various surgical applications including hernia and prolapse repairs, and P4HB regenerative polymer scaffolds for treating stress urinary incontinence. Additionally, the company produces surgical films and composite meshes designed to enhance tissue support and minimize attachment. Tepha's innovative materials are characterized by their flexibility, elasticity, biocompatibility, and excellent tensile strength, addressing unmet needs across multiple medical fields.

Velano Vascular, Inc. is a medical device company based in San Francisco, California, established in 2011. The company specializes in the development of needle-free vascular access devices, particularly its FDA-approved PIVO device. This innovative, single-use, and sterile device allows for blood collection from indwelling peripheral IV lines, significantly reducing the need for traditional needle sticks and central line access. Velano Vascular aims to enhance patient care by providing a painless and efficient blood draw option, thereby improving the experience for hospital inpatients while also offering a safer practice for healthcare providers. Additionally, the PIVO device presents a financially responsible alternative for health systems, addressing the challenges associated with conventional vascular access methods.

GSL Solutions is a medical technology company that specializes in the development of devices designed for the storage and tracking of controlled substances and patient-specific medications. The company's product line includes devices such as IntelliCab, IntelliVault, IntelliVault MTB, and IntelliVault RD, which enhance the security, efficiency, and compliance of medication storage. In addition to improving inventory management and regulatory compliance, these devices also provide analytic capabilities aimed at enhancing patient safety. Overall, GSL Solutions focuses on innovative solutions that facilitate better management of will-call prescriptions and controlled substances in the healthcare sector.

Cubex Systems develops cloud-based inventory management software specifically designed for the healthcare sector, including medical, dental, and veterinary markets. The software provides real-time reporting and intuitive analytics that help clients prioritize operational demands, manage spending, and ensure regulatory compliance. By utilizing this technology, organizations can effectively reduce costs associated with medication while optimizing their inventory supply management processes.

TVA Medical, Inc. is a medical device company based in Austin, Texas, focused on developing catheter-based solutions for end-stage renal disease and peripheral vascular diseases. Founded in 2009, the company specializes in innovative, minimally invasive therapies, notably through its everlinQ endoAVF system. This system facilitates the creation of an arteriovenous fistula using an endovascular approach, allowing for hemodialysis in patients with kidney failure. This method is designed to be less invasive than traditional surgical techniques, resulting in reduced trauma to blood vessels. TVA Medical operates as a subsidiary of Becton, Dickinson and Company and has received funding from Santé Ventures.

MedAware Ltd specializes in developing solutions aimed at detecting and eliminating prescription errors to enhance patient safety and reduce healthcare costs. Founded in 2012 and headquartered in Raanana, Israel, the company utilizes advanced data analytics and machine learning algorithms to analyze extensive electronic medical records. Its offerings include the MedAS alerting system for real-time alerts on prescription errors, MedRIM for risk management support, MedQC for quality control assistance, and MedRAF to reduce alert fatigue. These tools enable healthcare providers, pharmacy benefit management companies, and pharmacy chains to leverage big data effectively, identify potential prescription errors related to drug interactions, dosages, and allergies, and ultimately improve patient outcomes.

Magentiq Eye Ltd. is a medical device company based in Haifa, Israel, established in 2014. It specializes in developing advanced technologies for endoscopic procedures, particularly focusing on automatic polyp detection during colonoscopies. The company's flagship product, the Automatic Polyp Detection System (APDS), leverages deep learning and computer vision to enhance the accuracy of polyp identification, thereby reducing the miss rate during examinations. The APDS is available in two formats: APDS-RT, which operates in real-time by processing video feeds from endoscopic cameras, and APDS-OFL, which analyzes pre-recorded colonoscopy videos. Given the prevalence of colonoscopies—approximately 40 million performed annually—the system aims to improve patient outcomes by increasing detection rates and minimizing the risk of interval cancers. Magentiq Eye's technology not only supports physicians in making more informed decisions during procedures but also has the potential for integration with existing endoscopic equipment or as a service model for clinics and hospitals.

C. R. Bard, based in Murray Hill, New Jersey, is a prominent multinational company focused on the development, manufacturing, and marketing of innovative medical technologies. The company provides a range of specialized medical devices aimed at addressing the challenges faced by healthcare professionals and patients in various aspects of healthcare, including wellness, prevention, early diagnosis, treatment, and post-care management. C. R. Bard's product portfolio encompasses solutions for conditions such as peripheral vascular disease, end-stage renal disease, heart arrhythmias, urology diseases, various cancers, and soft tissue repairs. By offering advanced vascular, urology, oncology, and surgical specialty products, C. R. Bard aims to enhance patient outcomes and improve the overall quality of care in the medical field.

Caesarea Medical Electronics Ltd. specializes in designing and manufacturing a variety of infusion and syringe pump systems. Based in Caesarea, Israel, the company offers products such as epidural infusion pumps, dual and four-channel infusion pumps, ambulatory syringe pumps, and enteral feeding devices. Their range also includes intravenous medication delivery systems and multifunctional infusion therapy devices, along with disposable administration sets. The company emphasizes customization in its offerings, providing project-level adaptations including specialist disposables and software language modifications. Caesarea Medical Electronics caters to clinical research firms and various healthcare environments, including hospitals, home care, and emergency medical settings. Founded in 1993, the company is committed to delivering advanced technology that prioritizes patient safety and ease of use for operators.

CRISI Medical Systems, Inc. is a privately-funded medical device company focused on enhancing the safety and effectiveness of intravenous (IV) injectable medications. The company develops innovative drug delivery systems aimed at improving clinical outcomes and reducing healthcare costs. By prioritizing technology and innovation, CRISI Medical Systems strives to advance the standard of care in injectable drug delivery, ensuring that medications are administered more safely and accurately.

GenCell Biosystems is focused on advancing molecular biology through its innovative Composite Liquid Cell (CLC) platform technology. This technology enables a novel approach to confining, transporting, combining, processing, and analyzing biological reactions, which facilitates the extraction and preparation of samples, library preparation for next-generation sequencing, PCR genotyping, quantitative PCR, digital PCR, and proteomic assays. The versatility of CLCs allows them to be customized to meet diverse protocol requirements, addressing significant challenges in the fields of genomics and proteomics. By commercializing these instruments, GenCell aims to provide valuable tools for researchers in life sciences.

CareFusion is a provider of medical products and enterprise management solutions aimed at enhancing the safety and cost-effectiveness of healthcare. The company offers a range of medical technology products, including automated dispensing systems, patient identification solutions, respiratory ventilators, and surgical instruments that are essential for infection prevention, neurological monitoring, and diagnosis. By focusing on these areas, CareFusion assists healthcare organizations in achieving improvements in infection control, medication management, medical supply management, and respiratory care.

Alverix specializes in point-of-care diagnostics technology, focusing on the design and manufacture of low-cost, handheld reader devices that deliver laboratory-level accuracy and precision. The company collaborates with diagnostic and OEM manufacturers to enhance test accuracy, improve portability, and develop new assays suitable for various settings, including physician offices, laboratory outreach, retail clinics, and home use. Alverix emphasizes strong product design, development, and high-volume manufacturing capabilities, positioning itself at the forefront of shifting diagnostic testing from traditional laboratories to locations where rapid results are essential for effective patient care.

Cato Software Solutions is a healthcare software developer based in Vienna, Austria. The company specializes in creating automated systems designed to enhance data sharing and reduce human error in medical practices. Its software solutions focus on oncologic therapy planning, therapy monitoring, and the preparation of cytotoxic medications. Additionally, Cato Software Solutions provides tools for nurse bedside documentation, aiming to standardize practices within the healthcare industry and improve overall patient care.

Safety Syringes, Inc. designs, manufactures, and markets safety devices for the pharmaceutical industry in the United States, Canada, Europe, India, and the Russian Federation. It offers UltraSafe needle guards to attach to prefilled glass syringes used with vaccines, low molecular weight heparins, and other medicines.

Sirigen, Inc. is a biotechnology company based in La Jolla, California, specializing in High Sensitivity Fluorescence (HSF) detection technology for the diagnostic and life science markets. Founded in 2003, Sirigen develops innovative fluorescent polymers and conjugates that enhance stain index performance in flow cytometry. Their products are utilized in a variety of applications, including immunoassays, ELISA, biomarkers, proteomics, molecular diagnostics, and various forms of microscopy and blotting techniques. Sirigen's technology streamlines sample processing and instrumentation requirements, enabling efficient high-volume screening in diagnostics and personal care applications. The company operates as a subsidiary of Becton, Dickinson and Company.

BD Kiestra Total Lab Automation develops solutions and services for medical bacteriology laboratories. It offers total lab and work cell automation solutions, and automation/mechanization modules. The company also provides solutions and products for use in a water or food microbiology laboratories.

Carmel Pharma ab engages in the manufacture and distribution of products that improve the quality of life of people who prepare, administer, and dispose of hazardous drugs. It offers the PhaSeal System, a closed-system drug transfer device that prevents hazardous drug interaction with the environment. The company's PhaSeal product is implemented in various cancer centers, oncology practices, and specialty pharmacies in the United States, as well as facilities in Europe and Asia. Carmel Pharma ab was founded in 1994 and is headquartered in Mölndal, Sweden with an additional office in Columbus, Ohio.

Accuri Cytometers was founded to address a compelling need: life scientists love the rapid cell-by-cell analysis capability of flow cytometers, but too few have a flow cytometer in their lab. The barriers for most researchers include cost of the instrument, complexity of the software, effort required for maintenance, and the large amount of bench space required for the instrument. As a result, the company is looking to develop affordable and robust cytometers.

HandyLab is a medical technology company that develops and manufactures molecular diagnostic assays and automation platforms The company’s proprietary platform reduces the time, cost, and complexity of testing while improving the quality of results. Using patented real-time microfluidic PCR technology, its products are positioned to decentralize nucleic acid testing. HandyLab was founded in 2000 and is based in Ann Arbor, Michigan. It was acquired by Becton, Dickinson and Company in 2009.

Cytopeia Inc. is a company based in Seattle, Washington, that specializes in the manufacturing of automated influx cell sorters. These advanced instruments are designed to assist scientists in analyzing and characterizing cells, facilitating research across various fields, including cell therapy, stem cell research, drug discovery and development, and marine biology. By providing innovative solutions for cell sorting, Cytopeia aims to enhance the capabilities of researchers and contribute to advancements in biological studies and applications.

Plasso Technology is develops surface-critical research tools utilizing functional coating technology for applications in glycomics and cell culture. The company offers BD Heparin Binding Plate that immobilizes the heparin without modification

TriPath Imaging, Inc. manufactures and markets diagnostic equipment and products for cervical cytology screening. The company’s products include microbial identification tests for differential detection and identification of the causative agents for vaginitis; ethanol based fixative systems to collect, preserve, hemolyze, transport, and transfer cytology specimens to a glass slide; slide profilers for prioritizing slides based on likelihood of abnormality to help cytotechnologists reduce false negatives;

GeneOhm Sciences is a company that designs, develops, and delivers nucleic acid-based diagnostic solutions aimed at addressing unmet diagnostic needs across various diseases, including inherited diseases, infectious diseases, and oncology. Based in San Diego, California, and established in 2001, GeneOhm focuses on developing rapid diagnostic systems that can detect and identify infectious agents and genetic variations, providing results in under two hours. The company offers specific diagnostic tests, including an assay for methicillin-resistant Staphylococcus aureus (MRSA) and a test for Group B Streptococcus in pregnant women. Additionally, GeneOhm's technology includes a lysis kit for processing various sample types. In 2004, GeneOhm merged with Infectio Diagnostic, Inc., enhancing its portfolio with proprietary technology and industry expertise. The company was later acquired by the BD Pharmaceuticals group, further solidifying its position in the molecular diagnostics field.

ATTO Technology, Inc. is a leading provider of storage and network connectivity solutions tailored for data-intensive computing environments, with over 25 years of industry experience. Based in Amherst, NY, the company specializes in manufacturing a diverse range of products, including Host Bus Adapters, RAID adapters, network adapters, and Thunderbolt™-enabled Desklink™ devices. These solutions support various connectivity interfaces such as Fibre Channel, SAS, SATA, iSCSI, and Ethernet. ATTO's technology is designed to enhance the storage, management, and delivery of data, providing customers with a competitive edge in high-performance computing markets. The company distributes its offerings globally through partnerships with Original Equipment Manufacturers, Systems Integrators, Distributors, and Value Added Resellers. By focusing on real-world applications, ATTO leverages its engineering expertise to develop innovative solutions that meet the evolving demands of its clientele.

StemCo Biomedical, Inc. was founded in 1999 and is located in the Research Triangle Park area of NC. The Company is engaged in the development, manufacture and distribution of a series of medical products designed to improve therapeutic transplantation of adult hematopoetic stem and progenitor cells derived from bone marrow, peripheral blood or umbilical cord blood. Addressing a market of more than $1 billion annually, the Company will have a series of products on the market starting in 2002 that identify, sort and custom-engineer stem cell grafts based upon cellular expression of ALDH resulting in what may be better, more effective stem cell transplants in the future.

GENTEST Corporation specializes in developing innovative systems for the in vitro analysis of xenobiotic metabolism and toxicity, particularly focusing on drug metabolism and toxicology. Founded in 1983, the company initially concentrated on using cultured human cells for genotoxicity assays before expanding its research to include cytochrome P450 cDNA-expression techniques in 1985. This expansion led to the first commercial offering of cDNA-expressed human cytochrome P450 enzymes in 1990. GENTEST is recognized for its expertise in this field, with its scientists contributing to peer-reviewed journals and international symposia. The company’s products are essential for pharmaceutical and biotech industries, providing tools to screen drug candidates for adverse interactions and potential liver toxicity. Over the years, GENTEST has significantly broadened its range of products, enhancing the specificity and activity of its enzymes.

Saf-T-Med, Inc. (STM), a Chicago-based developer of patented needle technology designed to protect health care workers against accidental needlestick injuries.

Clontech Laboratories provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Clontech is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Clontech's mission is to develop high-quality innovative tools and services to accelerate discovery.

As of February 9, 1999, Biometric Imaging, Inc. was acquired by Becton, Dickinson and Company. Biometric Imaging, Inc. develops cell based diagnostic products and high throughput drug discovery technology. Their research is based on a proprietary technology called microvolume fluorimetry, and they primarily serve the transfusion medicine, infectious diseases, and oncology markets. The company was founded in 1991 and is based in Mountain View, California.